Aqr Capital Management LLC Surface Oncology, Inc. Transaction History

Aqr Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.42 - $3.15 $568,431 - $1.26 Million	-400,304 Reduced 88.97%	49,606 $81,000
Q1 2022 May 16, 2022	BUY	$2.65 - $5.08 $368,620 - $706,638	139,102 Added 44.75%	449,910 $1.32 Million
Q4 2021 Feb 14, 2022	BUY	$4.73 - $7.9 $806,952 - $1.35 Million	170,603 Added 121.68%	310,808 $1.49 Million
Q3 2021 Nov 15, 2021	BUY	$5.16 - $7.98 $628,090 - $971,349	121,723 Added 658.6%	140,205 $1.06 Million
Q2 2021 Aug 16, 2021	BUY	$6.45 - $9.09 $119,208 - $168,001	18,482 New	18,482 $138,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.